Rejuvenate Biomed SA
11.0 FTERejuvenate Biomed reported total assets of €3.45m at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026), with 11 full-time equivalents.
By total assets for 2025, Rejuvenate Biomed ranks among the 200 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Rejuvenate Biomed shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -51 % Headcount (avg FTE) +86 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Rejuvenate Biomed's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 01 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 28 Jun 2022
Rejuvenate Biomed's financial analysis
- Solvency-15.8%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Rejuvenate Biomed
Rejuvenate Biomed's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0681.964.735
- VAT number
- BE0681964735
- Peppol
- Registered · 0208:0681964735 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 02 Oct 2017
- Registered office
- 3590 Diepenbeek
- Size
- Small · 11.0 FTE
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Rejuvenate Biomed (SA) has been based in Diepenbeek since 2017, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €3.28m and equity of −543,937 €; its revenue is not published. With 11.0 full-time equivalents, it is a small enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Rejuvenate Biomed
Companies in the same business, of comparable size and area, outside its group.
- Grand Medical (Europe) Research and experimental development on natural sciences and engineering Niel · balance sheet 135,260 €
- Simabs Manufacture of pharmaceutical preparations Diepenbeek · balance sheet €2.67m
- ILiAD Biotechnologies Research and experimental development on natural sciences and engineering Ghent · balance sheet €1.06m
- Perseus Biomics Manufacture of basic pharmaceutical products Leuven · balance sheet €5.25m
- Blue3Berg Research and experimental development on natural sciences and engineering Zoersel · balance sheet 803,714 €
- Boehringer Ingelheim Veterinary Medicine Belgium NV Research and experimental development on natural sciences and engineering Evergem · balance sheet €6.51m
- ERC Belgium Research and experimental development on natural sciences and engineering Gembloux · balance sheet €11.6m
- Asterion Research & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €2.31m
Frequently asked questions about Rejuvenate Biomed
What is the revenue of Rejuvenate Biomed?
Rejuvenate Biomed files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Rejuvenate Biomed?
In Belgium, the VAT number is the company number prefixed with BE: BE0681964735 for Rejuvenate Biomed, if the company is VAT-registered. Its company number (CBE) is 0681.964.735.
Where is the registered office of Rejuvenate Biomed?
According to the CBE register, the registered office of Rejuvenate Biomed is in 3590 Diepenbeek.
What is the equity of Rejuvenate Biomed?
At the close of the 2025 financial year, the equity of Rejuvenate Biomed amounts to -543,937 €, a solvency of -15.8% of total assets.
How many people work at Rejuvenate Biomed?
11.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Rejuvenate Biomed?
The register lists 6 active mandates at Rejuvenate Biomed. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Rejuvenate Biomed within its sector?
By total assets for 2025, Rejuvenate Biomed ranks among the 200 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Rejuvenate Biomed
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →